Results 211 to 220 of about 55,357 (300)

Nanobody-Functionalized Magnetic Beads for Enrichment of Foodborne Botulinum Toxin Type A Light Chain. [PDF]

J Microbiol Biotechnol
Luong HT, Kieu MB, Phi HT, Nguyen NH, Luu QM, Vu CT, Pham DT, Pham YB, Nguyen LTH, Nguyen TT, Nguyen NTA, Trinh TV, Tran TT, Le NTH.   +13 more
europepmc   +1 more source

Relief of pain associated with spasticity in adult patients after treatment with onabotulinumtoxinA: Post hoc observational results from the ASPIRE study

PM&R, Volume 18, Issue 4, Page 410-425, April 2026.
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel, Cassandra List, Marc Schwartz, Mariana Nelson, Tiziana Musacchio, Esther Duarte   +5 more
wiley   +1 more source

Botulinum toxin type A inhibits chronic post-thoracotomy pain through the HMGB1-mediated TLR4/NF-κB signaling pathway. [PDF]

Am J Transl Res
Wei F, Lv B, Liu D, Zou X.
europepmc   +1 more source

Sleep Bruxism: A Narrative Review of Current Concepts, Mechanisms, and Clinical Implications

Journal of the Royal Society of New Zealand, Volume 56, Issue 2, April 2026.
Sleep bruxism is defined as “masticatory muscle activity during sleep that is characterized as rhythmic (phasic) or non‐rhythmic (tonic) and is not a movement disorder or a sleep disorder.” This comprehensive narrative review synthesizes current knowledge on the prevalence, risk factors, assessment, and management of sleep bruxism.
Ramesh Balasubramaniam, Daniele Manfredini, Guangzhao Guan   +2 more
wiley   +1 more source

Correction of Nasolabial Folds Using Polydioxanone Cog Threads Combined With Botulinum Toxin Type A: A Prospective Comparative Clinical Study. [PDF]

Cureus
Shinde SU, Mansuri S, Choudhary N, Pillai P, Deepak A, Tiwari RV, Dixit H, Gupta S.   +7 more
europepmc   +1 more source

Enhancing diabetic foot osteomyelitis diagnosis with metagenomics next‐generation sequencing, proof of concept

Diabetic Medicine, Volume 43, Issue 4, April 2026.
The use of mNGS with the MinION tool clearly provides a significant advantage compared to routine culture by identifying a higher diversity of pathogens in diabetic foot osteomyelitis. It also highlights the value of this method in clinical decision making, despite the technical challenges inherent in metagenomic sequencing.
Madjid Morsli, Chloé Magnan, Florian Salipante, Adeline Dubois, Sophie Schuldiner, Nicolas Cellier, Albert Sotto, Jean‐Philippe Lavigne, Catherine Dunyach‐Remy   +8 more
wiley   +1 more source

Botulinum Toxin Type A as a Therapeutic Agent in Epilepsy: Attenuation of Neuronal Ferroptosis and Cognitive Dysfunction. [PDF]

Brain Behav
Li S, Huang Z, Ma Y, Zheng Y, Du M, Lian Y.   +5 more
europepmc   +1 more source

Botulinum Toxin Type A in Red Ear Syndrome and a Novel Multi-nerve Injection Paradigm: A Case Report. [PDF]

Cureus
Clark MT, Meathrel KE.
europepmc   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 4, Page 939-949, April 2026.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza, Víctor Obach, Daniel Guisado‐Alonso, Fernando Velasco Juanes, Rocío Álvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Aintzine Ruisánchez, Natalia Roncero, Ane Mínguez‐Olaondo, Amaya Echeverria, Alba López‐Bravo, Ángel Luis Guerrero‐Peral, David García‐Azorín, Elisa Cuadrado‐Godia, Galca‐Only Study Group, Neus Fabregat, Marta Ruibal, Izaro Kortazar Zubizarreta, Nuria Riesco, Lucia González‐Fernández, Paula Manera, Agustín Oterino Duran, Yésica González‐Osorio, Santiago Fernández‐Fernández, Juan Carlos García‐Moncó, Isabel Fernández‐Pérez, Joan Jiménez‐Balado   +27 more
wiley   +1 more source

Clinical impacts of botulinum toxin type A injections for provoked vestibulodynia: insights from randomized controlled trials. [PDF]

BMC Womens Health
Gao Z, Hu L, Yi C, Gao C.
europepmc   +1 more source